WINDOXAL Trademark

Trademark Overview

On Friday, October 31, 2025, a trademark application was filed for WINDOXAL with the United States Patent and Trademark Office. The USPTO has given the WINDOXAL trademark a serial number of 99473952. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, March 18, 2026. This trademark is owned by Medicure Inc.. The WINDOXAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations
windoxal

General Information

Serial Number99473952
Word MarkWINDOXAL
Filing DateFriday, October 31, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, March 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 31, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedicure Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWinnipeg, Manitoba, MB R3T0P4
CA

Trademark Events

Event DateEvent Description
Friday, October 31, 2025NEW APPLICATION ENTERED
Friday, October 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 31, 2025APPLICATION FILING RECEIPT MAILED
Monday, March 16, 2026ASSIGNED TO EXAMINER
Monday, March 16, 2026NON-FINAL ACTION WRITTEN
Monday, March 16, 2026NON-FINAL ACTION E-MAILED
Monday, March 16, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 17, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 17, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 18, 2026SUSPENSION LETTER WRITTEN
Wednesday, March 18, 2026LETTER OF SUSPENSION E-MAILED
Wednesday, March 18, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

windoxal preparations pharmaceutical